Supplements Last reviewed: June 15, 2026

Does vitamin C shorten the common cold?

Moderate Evidence
Confidence Score 55%
⚖️

IT DEPENDS

Regular vitamin C supplementation modestly reduces cold duration by about 8% in adults and 14% in children, but taking it after symptoms start shows no consistent benefit. The effect is more pronounced in people under physical stress.

The Verdict

Regular vitamin C supplementation modestly reduces cold duration by about 8% in adults and 14% in children, but taking it after symptoms start shows no consistent benefit. The effect is more pronounced in people under physical stress.

What the Evidence Shows

Vitamin C (ascorbic acid) has been studied extensively for its role in immune function and the common cold. The largest body of evidence comes from Cochrane meta-analyses covering 29+ RCTs. Regular supplementation (≥200 mg/day) consistently shows a small reduction in cold duration—roughly half a day shorter in adults and a full day shorter in children. However, therapeutic use (starting vitamin C after symptom onset) has not reliably shortened colds in most trials. The exception is people under intense physical stress (marathon runners, soldiers in subarctic conditions), where regular supplementation reduced cold incidence by approximately 50%. Vitamin C supports neutrophil function, lymphocyte proliferation, and acts as an antioxidant in respiratory tissue, but these mechanisms do not translate into dramatic clinical effects for the average person. The evidence does not support megadose protocols (>2g/day) for cold prevention or treatment in the general population.

Evidence Quality

5

Meta-Analyses

29

RCTs

8

Observational

Important Caveats

  • ⚠️ Therapeutic use after symptom onset shows no consistent benefit
  • ⚠️ Effect size is small—about 8% reduction in duration for adults
  • ⚠️ People under extreme physical stress benefit more significantly
  • ⚠️ Doses above 1g/day do not provide additional benefit in most studies
  • ⚠️ Individual variation in baseline vitamin C status may influence results
  • ⚠️ High doses (>2g/day) may cause gastrointestinal discomfort

Population Studied

General adult population and children; subgroup analyses in athletes, military personnel, and those under physical stress

Dosage

Most studies used 200mg-2g/day; benefits plateau above 200mg/day for prevention

Duration

Regular supplementation studies lasted 2 weeks to 5 years; therapeutic trials measured single cold episodes

Supporting Studies (2)

Vitamin C for preventing and treating the common cold

Meta-Analysis

Hemilä H, Chalker E. · Cochrane Database of Systematic Reviews (2013)

Regular vitamin C supplementation (≥200 mg/day) reduced cold duration by 8% in adults and 14% in children across 29 trial comparisons involving 11,306 participants.

View paper (DOI) →

Vitamin C supplementation and the common cold—was Linus Pauling right or wrong?

review

Hemilä H. · Nutrients (2017)

In five trials with participants under heavy physical stress, vitamin C halved cold incidence (pooled RR 0.48), suggesting a meaningful benefit for physically active populations.

View paper (DOI) →

Contradicting Studies (1)

Vitamin C for the common cold: a double-blind trial

RCT

Audera C, Patulny RV, Sander BH, Douglas RM. · Medical Journal of Australia (2001)

In 400 volunteers randomized to 250mg, 1g, or 3g vitamin C at cold onset, no significant difference in cold duration or severity was found compared to placebo across all dose groups.

Why this disagrees:

Therapeutic dosing after symptom onset appears ineffective, suggesting vitamin C must be present in tissues before infection to exert its modest protective effect. Starting supplementation once a cold has begun does not meaningfully alter its course.

View paper (DOI) →
Share:
Was this helpful?

Related Claims